Russell Investments Group
HZNP

Russell Investments Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Russell Investments Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-133,657
Closed -$15.5M – 3369
2023
Q3 		$15.5M Sell
133,657
-17,399
-12% -$1.87M 0.03% 568
2023
Q2 		$15.5M Sell
151,056
-260,263
-63% -$27.5M 0.03% 575
2023
Q1 		$44.9M Sell
411,319
-58,256
-12% -$6.44M 0.09% 263
2022
Q4 		$53.4M Sell
469,575
-62,080
-12% -$5.16M 0.11% 222
2022
Q3 		$32.9M Buy
531,655
+412,354
+346% +$28.8M 0.07% 328
2022
Q2 		$9.52M Sell
119,301
-12,990
-10% -$1.23M 0.02% 797
2022
Q1 		$13.9M Sell
132,291
-687
-0.5% -$67K 0.02% 693
2021
Q4 		$14.3M Sell
132,978
-7,128
-5% -$778K 0.02% 732
2021
Q3 		$15.3M Buy
140,106
+15,590
+13% +$1.62M 0.03% 699
2021
Q2 		$11.7M Buy
124,516
+48,505
+64% +$4.46M 0.02% 854
2021
Q1 		$6.98M Buy
76,011
+22,825
+43% +$1.93M 0.01% 1169
2020
Q4 		$3.88M Sell
53,186
-29,757
-36% -$2.21M 0.01% 1387
2020
Q3 		$6.44M Sell
82,943
-2,605
-3% -$179K 0.01% 993
2020
Q2 		$4.75M Sell
85,548
-88,825
-51% -$3.8M 0.01% 1127
2020
Q1 		$5.16M Sell
174,373
-310,843
-64% -$10.5M 0.01% 938
2019
Q4 		$17.6M Sell
485,216
-234,876
-33% -$7.2M 0.03% 610
2019
Q3 		$19.7M Sell
720,092
-30,648
-4% -$792K 0.04% 538
2019
Q2 		$18.1M Buy
750,740
+95,602
+15% +$2.43M 0.03% 602
2019
Q1 		$17.3M Sell
655,138
-17,679
-3% -$419K 0.03% 635
2018
Q4 		$13.1M Sell
672,817
-93,118
-12% -$1.83M 0.03% 682
2018
Q3 		$15M Buy
765,935
+290,346
+61% +$5.52M 0.03% 728
2018
Q2 		$7.88M Buy
475,589
+25,652
+6% +$391K 0.02% 1033
2018
Q1 		$6.39M Buy
449,937
+258,997
+136% +$3.83M 0.01% 1217
2017
Q4 		$2.85M Buy
190,940
+37,272
+24% +$523K ﹤0.01% 1648
2017
Q3 		$1.95M Hold
153,668
– – ﹤0.01% 1797
2017
Q2 		$1.82M Buy
153,668
+69,626
+83% +$866K ﹤0.01% 1785
2017
Q1 		$1.24M Sell
84,042
-21,034
-20% -$341K ﹤0.01% 1988
2016
Q4 		$1.7M Buy
+105,076
New +$1.91M ﹤0.01% 1891

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's HZNP Position: Q4 2023 in Review

Russell Investments Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 133,657 shares — an estimated $15.5M sold.

Russell Investments Group first reported a position in HZNP in Q4 2016 and held it in 28 quarters. The position peaked at $53.4M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Russell Investments Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Russell Investments Group sold 133,657 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $15.5M.
  • Russell Investments Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 28 quarters.
  • Russell Investments Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $53.4M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Russell Investments Group's 13F filing for Q4 2023, filed 5 Feb 2024.